HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Uppsala University Hospital was the first in Europe to initiate an academic CAR T study for patients with B-cell lymphoma. Five years later, in 2019, the first patient was treated within standard ...

Tandem-target CAR-T produced a response in all participants with relapsed or refractory mantle cell lymphoma in a phase 1/2 study. Patients received their CAR-T within 8 to 12 days of lymphodepletion.

Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of non-Hodgkin's lymphomas and is a rare but aggressive form of T-cell lymphoma that usually occurs in children and young adults.

Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of non-Hodgkin's lymphomas and is a rare but aggressive form of T-cell lymphoma that usually occurs in children and young adults.

The studies span breast cancer and other solid tumors (glioblastoma, endometrial cancer, lung cancer, gastric cancer), as well as multiple blood cancers (multiple myeloma, large B-cell lymphoma ...

The most advanced Galapagos cell therapy program is GLPG5101. Though Galapagos generated encouraging early clinical data for this therapy in non-Hodgkin lymphoma ... its CAR T-platform alone ...